---
title: "301520.SZ (301520.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301520.SZ/news.md"
symbol: "301520.SZ"
name: "301520.SZ"
parent: "https://longbridge.com/en/quote/301520.SZ.md"
datetime: "2026-03-17T20:30:03.339Z"
locales:
  - [en](https://longbridge.com/en/quote/301520.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301520.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301520.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301520.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301520.SZ/news.md)


# 301520.SZ (301520.SZ) — Related News

### [The Top Ten Most Anticipated Pharmaceutical IPOs of 2026](https://longbridge.com/en/news/277133984.md)
*2026-02-27T02:52:35.000Z*
> The core theme of pharmaceutical investment in 2026 is "certainty." This article reviews 10 pharmaceutical companies tha

### [AHWB: Expected net profit in 2025 to decline by 50.70%-66.55% year-on-year](https://longbridge.com/en/news/274280619.md)
*2026-01-30T09:15:07.000Z*
> AHWB announced that it expects the net profit attributable to shareholders of the listed company for the fiscal year 202

### [AHWB released its performance for the first three quarters, with a net profit attributable to the parent company of 33.1106 million yuan, a decrease of 57.44%](https://longbridge.com/en/news/262232353.md)
*2025-10-22T11:46:02.000Z*
> AHWB released its third-quarter report for 2025, with operating revenue of 209 million yuan in the first three quarters,

### [The innovative drug concept fell at the beginning of the session, with Cosunter down 10%](https://longbridge.com/en/news/244994941.md)
*2025-06-18T01:28:32.000Z*
> The innovative drug concept opened lower, with Cosunter down 10%, and Qianhong Bio-pharma, PKU HEALTHCARE, AHWB, Hicin P

### [](https://longbridge.com/en/news/244801498.md)
*2025-06-17T01:32:29.000Z*
> The A-share innovative drug concept opened with a surge, with AHWB and Cosunter rising over 10%, followed by Beilu Pharm

### [](https://longbridge.com/en/news/243990233.md)
*2025-06-11T03:19:29.000Z*
> The A-share CRO concept fluctuated and declined, LIANHE TECHNOLOGY once again hit the limit down, AHWB, HC CHEMICAL, HYB

### [The medical services sector has seen a short-term decline, with Kingchem falling over 8%](https://longbridge.com/en/news/243186677.md)
*2025-06-05T01:33:23.000Z*
> The medical services sector has seen a short-term decline, with Kingchem dropping over 8%, followed by PR, Bio-S, HitGen

### [Ergothioneine receives attention, multiple listed companies respond to related questions](https://longbridge.com/en/news/240689685.md)
*2025-05-18T02:13:01.000Z*
> Ergothioneine has recently attracted market attention, with several listed companies responding to related questions on 

### [AHWB released its 2024 annual performance, with a net profit attributable to the parent company of 85.5307 million yuan, a decrease of 20.87%](https://longbridge.com/en/news/236785262.md)
*2025-04-21T11:56:03.000Z*
> AHWB released its 2024 annual report, with operating revenue of 379 million yuan, a year-on-year increase of 10.91%. The

### [AHWB released its first-quarter performance, with a net profit attributable to the parent company of 11.8493 million yuan, a decrease of 60.09%](https://longbridge.com/en/news/236783715.md)
*2025-04-21T11:51:04.000Z*
> AHWB released its Q1 2025 performance report, with operating revenue of 71.0522 million yuan, a year-on-year decrease of